A newly discovered virus, harbored within a common gut bacterium, is linked to a significantly increased risk of colorectal cancer, according to an international study. The findings, published February 7 in Nature Communications Medicine, represent a potential shift in understanding the complex interplay between the gut microbiome and cancer development, though researchers emphasize this is an early stage discovery.
Colorectal cancer remains a leading cause of cancer-related deaths worldwide, and current risk stratification methods have limitations. While factors like age, diet, and lifestyle are known contributors, the precise biological triggers remain elusive. This has led to growing interest in the gut microbiome – the vast community of microorganisms living in the digestive tract – as a potential driver of the disease. Identifying clinically significant signals within this complex ecosystem has proven challenging for both researchers, and clinicians.
The research, led by scientists at the University of Southern Denmark and Odense University Hospital, focused on Bacteroides fragilis, a bacterium frequently found in the human gut. Researchers identified distinct bacteriophages – viruses that infect bacteria – within B. Fragilis that are associated with colorectal cancer. These viruses, the team characterized, are previously unknown types. The study suggests that interactions between the bacterium and its resident viruses could play a role in the biology of colorectal cancer.
Tracing the Viral Link Through Population Data
The investigation began in Denmark, utilizing data from a population study encompassing approximately two million citizens. Researchers initially focused on patients experiencing severe bloodstream infections caused by Bacteroides fragilis. A subset of these patients received a colorectal cancer diagnosis within weeks of the infection. Comparing the genetic material of the bacteria from patients with and without cancer revealed that isolates of B. Fragilis from cancer patients more frequently contained specific prophages – viruses embedded within the bacterial genome.
This initial pattern, observed in a relatively small sample of Danish patients, was then examined in larger, international datasets. To validate the findings, the team analyzed fecal samples from 877 individuals with and without colorectal cancer across Europe, the United States, and Asia. The results showed that patients with colorectal cancer were approximately twice as likely to carry traces of the identified viruses. Preliminary analysis indicated that the viral sequences identified around 40% of cancer cases, while the majority of healthy individuals did not carry them.
Association, Not Causation, and Future Research Directions
Researchers are careful to emphasize that the study demonstrates a statistical association, not a causal relationship. “We have identified a virus that is more common in people with colorectal cancer, but we haven’t proven that the virus causes cancer,” explained Flemming Damgaard, a molecular biologist and doctor at the Department of Clinical Microbiology at Odense University Hospital and the University of Southern Denmark.
The team is currently pursuing several avenues of research. These include cultivating B. Fragilis carrying the virus in an artificial gut model, examining tumor tissue for the presence of both the bacteria and the virus, and conducting studies in cancer-prone mice. They are likewise investigating whether the virus can be used as a biomarker to identify individuals at higher risk of developing the disease.
Potential for Early Detection
The possibility of using fecal tests to detect these viruses as a potential screening tool is being explored. “At the short term, People can investigate if the virus can be used to identify people at higher risk,” Damgaard added. The researchers acknowledge the complexity of the gut microbiome, noting that previously, searching for cancer-related signals felt like “looking for a needle in a haystack.” Their approach, focusing on viral components within bacteria, offers a more targeted strategy.
The University of Southern Denmark website provides further information about the research institution, and details about the Odense University Hospital can be found here.
The study’s findings underscore the growing recognition of the gut microbiome’s role in cancer development. While much remains unknown, this research offers a promising new avenue for understanding and potentially preventing this devastating disease. The next step will be to determine whether the virus is a contributing factor to colorectal cancer or simply a marker of an altered gut environment.
Have thoughts on this story? Share your comments below, and consider sharing this article with your network.
